HomeILA • ASX
Island Pharmaceuticals Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 48.42K | -89.90% |
Operating expense | 449.07K | 5.57% |
Net income | -766.71K | -32.76% |
Net profit margin | -1.58K | -1,214.70% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.99M | 309.02% |
Total assets | 4.31M | 144.04% |
Total liabilities | 419.62K | -62.81% |
Total equity | 3.89M | — |
Shares outstanding | 181.60M | — |
Price to book | 7.50 | — |
Return on assets | -43.71% | — |
Return on capital | -48.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -766.71K | -32.76% |
Cash from operations | -537.62K | 20.43% |
Cash from investing | — | — |
Cash from financing | 1.70M | 1,020.34% |
Net change in cash | 1.17M | 328.12% |
Free cash flow | -451.11K | -21.78% |
Previous close
$0.15
Day range
$0.16 - $0.17
Year range
$0.050 - $0.28
Market cap
33.64M AUD
Avg Volume
133.97K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
2017
Website
